title: Therapeutics: Embracing instability.
authors.forename: Nicola
authors.initials: N
authors.lastname: McCarthy
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001381:Azepines / Q000494:pharmacology*; D001552:Benzazepines / Q000494:pharmacology*; D018797:Cell Cycle Proteins / Q000378:metabolism*; D044783:F-Box Proteins / Q000378:metabolism*; D006801:Humans; D009447:Neuroblastoma / Q000188:drug therapy*; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000378:metabolism*; D046988:Proteasome Endopeptidase Complex / Q000502:physiology*; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors*; D016271:Proto-Oncogene Proteins c-myc / Q000378:metabolism*; D011743:Pyrimidines / Q000494:pharmacology*; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D001381:Azepines; D001552:Benzazepines; D018797:Cell Cycle Proteins; D044783:F-Box Proteins; D016271:Proto-Oncogene Proteins c-myc; D011743:Pyrimidines; D044767:Ubiquitin-Protein Ligases; D017346:Protein Serine-Threonine Kinases; D046988:Proteasome Endopeptidase Complex